Argus Investors Counsel Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.4% in the second quarter, Holdings Channel reports. Argus Investors Counsel Inc.’s holdings in Abbott Laboratories were worth $788,000 at the end of the most recent quarter. Get Abbott Laboratories alerts:Abbott Laboratories Trading Up 0.2%NYSE:ABT opened at $133.62 on Friday. Abbott Laboratories Company Profile(Free Report)Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Receive News & Ratings for Abbott Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abbott Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.